BioMarin Pharmaceutical Inc.

NasdaqGS:BMRN Stock Report

Market Cap: US$12.7b

BioMarin Pharmaceutical Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:BMRN Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
12 Nov 24SellUS$350,324C. GuyerIndividual5,278US$66.37
06 Mar 24SellUS$172,223Jean-Jacques BienaimeIndividual2,000US$86.71
05 Mar 24SellUS$3,010,396Henry FuchsIndividual35,341US$85.18
27 Feb 24SellUS$90,350Jean-Jacques BienaimeIndividual1,000US$90.35

Insider Trading Volume

Insider Buying: BMRN insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of BMRN?
Owner TypeNumber of SharesOwnership Percentage
State or Government176,6350.0927%
Individual Insiders1,481,9770.778%
General Public4,645,6572.44%
Hedge Funds9,753,2935.12%
Institutions174,525,45491.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 73.41% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11.9%
BlackRock, Inc.
22,623,503US$1.5b-0.51%0.02%
10.1%
The Vanguard Group, Inc.
19,278,654US$1.3b1.5%0.02%
9.9%
PRIMECAP Management Company
18,867,435US$1.3b0.41%0.9%
7.29%
Dodge & Cox
13,898,318US$929.7m-0.23%0.31%
5.51%
Capital Research and Management Company
10,494,955US$702.0m8.28%0.03%
5.12%
Viking Global Investors LP
9,753,293US$652.4m38.1%2.25%
4.63%
State Street Global Advisors, Inc.
8,823,114US$590.2m-8.44%0.02%
2.25%
Columbia Management Investment Advisers, LLC
4,281,482US$286.4m-8.93%0.06%
1.9%
Norges Bank Investment Management
3,619,503US$242.1m0%0.02%
1.84%
Elliott Management Corporation
3,500,338US$234.1m0%1.79%
1.71%
Geode Capital Management, LLC
3,260,050US$218.1m1.9%0.02%
1.26%
JP Morgan Asset Management
2,395,972US$160.3m6.03%0.02%
1.21%
BNY Asset Management
2,307,338US$154.3m-0.77%0.03%
1.07%
Avoro Capital Advisors LLC
2,038,015US$136.3m-55.3%1.91%
0.91%
UBS Asset Management AG
1,742,424US$116.6m24.6%0.01%
0.8%
Deutsche Asset & Wealth Management
1,533,072US$102.5m-14.5%0.03%
0.78%
Northern Trust Global Investments
1,484,358US$99.3m-5.95%0.01%
0.77%
Legal & General Investment Management Limited
1,471,049US$98.4m-3.15%0.02%
0.74%
Charles Schwab Investment Management, Inc.
1,401,628US$93.8m4.14%0.02%
0.7%
Dimensional Fund Advisors LP
1,339,721US$89.6m29.5%0.01%
0.65%
Rothschild & Cie Gestion
1,230,709US$82.3m0%1.44%
0.63%
Citadel Advisors LLC
1,204,397US$80.6m116%0.09%
0.61%
1832 Asset Management L.P.
1,164,391US$77.9m4,920%0.1%
0.58%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
1,096,300US$73.3m11.4%0.02%
0.57%
Palo Alto Investors LP
1,090,056US$72.9m-3.55%10.34%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/30 20:54
End of Day Share Price 2024/12/30 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

BioMarin Pharmaceutical Inc. is covered by 56 analysts. 27 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jack AllenBaird
Ishan MajumdarBaptista Research
Huidong WangBarclays